Acromegaly Drug Market 2020 To Witness Astonishing Growth | Leading Players are Takeda Pharmaceuticals, Novartis, Chiasma,Daewoong, Bausch Health, Pfizer, Johnson & Johnson, F. Hoffmann-La Roche, Smiths Medical, Sanofi, Medtronic

The primary sources employed while generating this Acromegaly Drug Market report include the industry experts from the industry comprising the management corporation, processing organizations, analytical service suppliers of the industry’s value chain. All primary sources are interviewed to accumulate the data and validate qualitative & quantitative information and conclude future prospects. Secondary research consists of key data about the industry value chain, the complete pool of major players, and application areas. The Acromegaly Drug Market report assist in market segmentation according to industry latest & upcoming trends to the bottom-most level, topographical markets and key advancement from both market and technology aligned perspectives.

Get Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-acromegaly-drug-market&rp

Market Analysis: Global Acromegaly Drug Market

Global acromegaly drug market is rising gradually with a substantial CAGR of 5.10% in the forecast period of 2019-2026. This rise in market value can be attributed in increase in awareness and concerns regarding the health of patients, increasing prevalence of growth hormone disorders and high expenditure in healthcare sector.

Key Market Players:

Few of the major competitors currently working in the global acromegaly drug market are Takeda Pharmaceutical Company Limited, Novartis AG, Chiasma, Inc, Crinetics Pharmaceuticals, Peptron, Daewoong. Co.LTD, Silence Therapeutic, Strongbridge Biopharma plc, Amryt Pharma plc, Foresee Pharmaceuticals Co., Ltd, Ipsen Pharma, Enesi, ALLERGAN, Bausch Health, Pfizer Inc, Johnson & Johnson Services, Inc, F. Hoffmann-La Roche Ltd., Smiths Medical, Inc., Rocket Medical plc., Novo Nordisk A/S, Sanofi, Medtronic and few among others.

Get Full TOC, Tables and Figures of Market Report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-acromegaly-drug-market&rp

Market Definition: Global Acromegaly Drug Market

Acromegaly is a rare hormonal disorder also known as gigantism. It occurs when pituitary gland releases excessive growth hormone in the body due to the tumor formation in the pituitary gland. This abnormal production of growth hormone results in the bone enlargement. It mainly affects the geriatric  population.

According to the article published in the  BioMed Central Ltd , it is estimated that total incidence population of acromegaly is  around 40 to 70 cases per million worldwide. and the prevelance is upto 100 to 130 per million. Hence with this growing cases of acromegaly worldwide will enhance the demand of the market.

Segmentation: Global Acromegaly Drug Market

Acromegaly Drug Market : By Mechanism of Action

Growth Hormone Receptor Antagonists
Dopamine Agonists
Somatostatin Analogs

Acromegaly Drug Market : By Diagnosis

Medical Imaging
Medical Laboratory Investigations

Acromegaly Drug Market : By Treatment Type

Medications
Radiation Therapy
Surgery

Acromegaly Drug Market : Drug Type

Sandostatin
Somavert
Bromocriptine
Parlodel
Octreotide
Pegvisomant
Pasireotide
Lanreotide

Acromegaly Drug Market : By Route of Administration

Oral
Intravenous
Subcutaneous
Intramuscular
Others

Acromegaly Drug Market : By End Users

Hospitals
Homecare
Specialty clinics
Surgical centers
Others

Acromegaly Drug Market : By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Acromegaly Drug Market Drivers:

Increasing prevalence of acromegaly is a factor driving the market growth

Changing lifestyle of the people across the globe is enhancing the market growth

Increasing incidence of genetic diseases is acting as a catalyst for the market growth

Increasing prevalence of hormonal diseases, endocrine diseases and hypopituitarism is elevating the market growth

Acromegaly Drug Market Restraints:

Unavailability of precise treatment and high cost of the surgery may restrain the growth of the market

Stringent government policies and a medical scheme such as providing subsidized drugs and reimbursement in the developing countries is likely to slow down the rate of treatment in the region in the forecast period

Lack of awareness of the people about the genetic and hormonal disorder is hampering the market growth

Key Developments in the Market:

In June 2018, Crinetics Pharmaceuticals received an award of USD 1.30 mm from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to fund the research and development of CRN00808 for the treatment of acromegaly which will help to advance potential treatment for the patients suffering from acromegaly.

In December 2014, Novartis AG received the FDA’s approval for Signifor (pasireotide) which is a somatostatin receptor agonist. This drug is used for the treatment of acromegalic patients untreated with surgery.

Reasons to Purchase this Report:

Current and future of global acromegaly drug market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Acromegaly Drug Market analysis report offers strategic & tactical support to clients for making well-informed business decisions. DBMR team provides customization of this market report according to the business needs. Contact sales team, who will assure to get a report that suits the necessities. The report carefully examines the global Acromegaly Drug Market, with a focus on most of the major players and their business strategies, geographical scope, market segments, product landscape and price, and cost structure. Such market report is made available for industries, individuals, and organizations across the globe, and offerings are delivered in the shortest possible turnaround time.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-acromegaly-drug-market&rp

Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com

About Data Bridge Market Research :

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.